In 2019, entrepreneur Bryan Johnson began experimenting with rapamycin, a drug usually used to prevent organ rejection, to try to extend his life. However, by September 2024, he stopped due to side effects like skin infections and high glucose levels. Johnson, who sold his company Braintree to PayPal for $800 million, is part of a trend among tech entrepreneurs who experiment with their bodies to live longer, often sharing their experiences online. His Blueprint protocol aims to treat chronic conditions with advanced diagnostics and personalized therapies. This trend of biohacking has seen influencers like Tim Ferriss warn against certain supplements, such as exogenous ketones, due to potential health risks. These practices highlight the ongoing debate about the safety and effectiveness of life-extension methods.
QUESTION: How might the trend of biohacking and self-experimentation influence future medical practices and public health policies?
Tech titans are hacking their bodies for a longer life: is there science behind their methods?
